Europe Head and Neck Cancer Diagnostics Market is expected to grow at a significant rate of nearly 10.85% CAGR during the forecast period 2019-2024.
Head and Neck cancer which is among the 10 most commonly caused cancers worldwide are prevalent extensively in regions where the consumption of alcohol and tobacco is high. To have the best chance of curing these type of diseases, early detection, and prompt treatment offer plays a key role. A rising number of diagnostic procedures for head and neck cancer, particularly pharyngeal and oral cancers, are few factors inducing the market growth.
The increase in the demand for diagnostic imaging market, advancements in modes of treatment, and incorporation of new innovations and novel technologies in diagnostic equipment are believed to further propel the growth of the market during the forecast period.
There is a surge in the aging population increasing the prevalence of chronic diseases, especially cancers related to head and neck, increasing the awareness towards cancer. This resulted in rising the healthcare expenditure of people and the government. However, there are few factors hindering the growth of the market like Low Adoption Rate of Digital Technology-Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets
Europe Head and Neck Cancer Diagnostics Market segmented and sub-segmented into the following categories:
Key market participants in the Europe Head and Neck Cancer Diagnostics Market Profiled in the Report are Philips Healthcare, GE Healthcare, Varian Siemens Healthcare, Medical Systems, Shimadzu Corporation, Velscope VX, Identafi and AdDent Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Test type
5.1.1 Diagnostic imaging
5.1.1.1 PET/CT
5.1.1.2 MRI
5.1.1.3 X-ray
5.1.1.4 Barium Swallow test
5.1.2 Biopsy
5.1.2.1 Incisional Biopsy
5.1.2.2 Fine needle aspiration Biopsy
5.1.2.3 HPV testing
5.1.3 Endoscopy
5.1.3.1 Pharyngoscopy
5.1.3.2 Laryngoscopy
5.1.3.3 Panendoscopy
5.1.4 Dental diagnostics
5.1.4.1 Fluorescence Visualization
5.1.4.2 Toluidine blue dye based method
5.1.4.3 Acetic acid rinse method
5.1.4.4 Brush biopsy
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 3M ESPE DENTAL SOLUTIONS
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 BIOMET 3I
8.3 DENTSPLY INTERNATIONAL, INC
8.4 HENRY SCHEIN, INC.
8.5 KERR CORPORATION
8.6 IVOCLAR VIVADENT AG
8.7 NOBEL BIOCARE
8.8 PATTERSON COMPANIES, INC.
8.9 ULTRADENT PRODUCTS
8.10 ZIMMER DENTAL
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
